Literature DB >> 21520033

The role of galectins in colorectal cancer progression.

Hannah Barrow1, Jonathan M Rhodes, Lu-Gang Yu.   

Abstract

Galectins constitute a family of 15 mammalian galactoside-binding proteins that share a consensus amino acid sequence in their carbohydrate binding sites. They are multi-functional molecules and are expressed widely in human tissues. Four galectins: galectin -1, -3, -4 and -8 are expressed in the human colon and rectum and their expressions show significant changes during colorectal cancer development and metastasis. These changes in galectin expression correlate with alterations in cancer cell growth, apoptosis, cell-cell and cell-matrix interactions and angiogenesis. This review summaries current knowledge of the expression and roles of these galectins in the progression of human colorectal cancer and discusses the relevance of galectins and their ligands as potential therapeutic targets for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21520033     DOI: 10.1002/ijc.25945

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Clinicopathological significance of galectin-1 expression and percentage of galectin-1-expressing T cells in clear-cell renal cell carcinoma.

Authors:  Yajuan Su; Wentao Wang; Yongpeng Xu; Wei Liangjun; Yanjie Wang; Changfu Li; Lichen Teng
Journal:  Can Urol Assoc J       Date:  2018-03-25       Impact factor: 1.862

2.  The clinical implication of tumoral Gal-1 expression in laryngeal squamous cell carcinomas.

Authors:  J Ye; H Liu; Y Hu; G Wan; J Li; Z Wang; P Li; G Zhang; Y Li
Journal:  Clin Transl Oncol       Date:  2013-01-29       Impact factor: 3.405

3.  Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.

Authors:  Florence Lefranc; Véronique Mathieu; Robert Kiss
Journal:  World J Biol Chem       Date:  2011-09-26

4.  Tumor cells interact with red blood cells via galectin-4 - a short report.

Authors:  Reham Helwa; Anette Heller; Stian Knappskog; Andrea S Bauer
Journal:  Cell Oncol (Dordr)       Date:  2017-03-14       Impact factor: 6.730

5.  Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence.

Authors:  Koichi Ito; Stephen J Ralph
Journal:  Clin Exp Metastasis       Date:  2012-04-07       Impact factor: 5.150

Review 6.  Antidepressant fluoxetine and its potential against colon tumors.

Authors:  Helga Stopper; Sergio Britto Garcia; Ana Maria Waaga-Gasser; Vinicius Kannen
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

7.  Simultaneous determination of serum galectin-3 and -4 levels detects metastases in colorectal cancer patients.

Authors:  Hannah Barrow; Jonathan M Rhodes; Lu-Gang Yu
Journal:  Cell Oncol (Dordr)       Date:  2012-11-02       Impact factor: 6.730

8.  High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.

Authors:  Jie Chen; Dong Tang; Sen Wang; Qing-Guo Li; Ji-Ran Zhang; Ping Li; Qi Lu; Gang Niu; Jun Gao; Nian-Yuan Ye; Dao-Rong Wang
Journal:  Tumour Biol       Date:  2013-11-16

9.  Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Sirintip Boonjaraspinyo; Somchai Pinlaor; Chawalit Pairojkul; Yaovalux Chamgramol; Yuzo Takahashi
Journal:  Tumour Biol       Date:  2012-02-29

10.  Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.

Authors:  Alejandro J Cagnoni; María Laura Giribaldi; Ada G Blidner; Anabela M Cutine; Sabrina G Gatto; Rosa M Morales; Mariana Salatino; Martín C Abba; Diego O Croci; Karina V Mariño; Gabriel A Rabinovich
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.